Hepatitis B Virus Elimination Strategies

Author:

Xu Mimi,Terrault Norah A.

Abstract

Abstract Purpose of Review The World Health Assembly called to eliminate viral hepatitis as a public health threat in 2016 and proposed elimination goals by 2030. This review examined current national and global progress with hepatitis B virus elimination, and the hurdles and solutions being undertaken to achieve elimination goals. Recent Findings Few countries are on target to achieve the elimination targets of a 95% reduction in new infections and a 65% reduction in mortality by 2030. Gaps towards elimination remain, such as low infant vaccine coverage in low-income countries and continued under-diagnosis and low rates of treatment globally. Summary HBV elimination is feasible but will require continued focus on infant and childhood vaccine coverage, improving blood and injection safety, increasing harm reduction measures among persons who use drugs, and providing broader access to low-cost diagnostics and antiviral treatment.

Funder

Gilead Sciences, GSK, Eiger Pharmaceuticals

University of Southern California

Publisher

Springer Science and Business Media LLC

Reference94 articles.

1. • Razavi-Shearer D, Gamkrelidze I, Pan C, Jia J, Berg T, Gray R, et al. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study. Lancet GastroenterolHepatol [Internet]. 2023 Jul 27 [cited 2023 Aug 9]; Available from: https://www.sciencedirect.com/science/article/pii/S2468125323001978. This provides estimates of country, regional, and global prevalence of hepatitis B virus infection in 2022 and the effects of treatment and prevention on disease burden.

2. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022–2030 [Internet]. [cited 2023 Aug 7]. Available from: https://www.who.int/publications-detail-redirect/9789240053779

3. Global hepatitis report, 2017 [Internet]. [cited 2022 Jun 22]. Available from: https://www-who-int.libproxy2.usc.edu/publications-detail-redirect/9789241565455

4. Lan Y, Wang H, Weng H, Xu X, Yu X, Tu H, et al. The burden of liver cirrhosis and underlying etiologies: results from the Global Burden of Disease Study 2019. Hepatol Commun. 2023;7(2):e0026.

5. Choi S, Kim BK, Yon DK, Lee SW, Lee HG, Chang HH, et al. Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990–2019: a DALY-based analysis of the Global Burden of Disease 2019 study. Clin Mol Hepatol. 2023;29(2):433–52.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3